APA (7th ed.) Citation

Brandes, A., Capper, D., & Wick, W. (2016). A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma. Neuro-Oncology, 18(8), . https://doi.org/10.1093/neuonc/now009

Chicago Style (17th ed.) Citation

Brandes, Alba, David Capper, and Wolfgang Wick. "A Phase II Randomized Study of Galunisertib Monotherapy or Galunisertib Plus Lomustine Compared with Lomustine Monotherapy in Patients with Recurrent Glioblastoma." Neuro-Oncology 18, no. 8 (2016). https://doi.org/10.1093/neuonc/now009.

MLA (9th ed.) Citation

Brandes, Alba, et al. "A Phase II Randomized Study of Galunisertib Monotherapy or Galunisertib Plus Lomustine Compared with Lomustine Monotherapy in Patients with Recurrent Glioblastoma." Neuro-Oncology, vol. 18, no. 8, 2016, https://doi.org/10.1093/neuonc/now009.